Valuation BLS Pharmaceuticals Limited OTC Markets

Stocks

Real-time OTC Markets			5-day change	1st Jan Change
- ^USD	-.--%		-.--%	-

07-26	BLS Pharmaceuticals Reports Record Revenue in June Quarter; Fiscal 2026 Revenue Hits Top End of Guidance Range	MT
06-02	Bioxyne Limited Announces Appointment of Edward Myer as Independent Non-Executive Director and Independent Chair of Audit and Finance Committee	CI

Data adjusted to current consolidation scope

Fiscal Period: June	2020	2021	2022	2023	2024	2025
Market Cap ¹	6.401	17.92	7.682	38.03	10.23	88.76
Change	-	180%	-57.14%	395.11%	-73.09%	767.35%
Enterprise Value (EV) ¹	4.701	16.32	5.514	34.75	9.916	82.62
Change	-	247.2%	-66.22%	530.16%	-71.46%	733.27%
P/E	-10.8x	-35x	-30x	-13.9x	-0.72x	17.8x
PBR	2.5x	9.53x	4.07x	2.51x	2.84x	7.15x
PEG	-	2.6x	0.6x	-0x	-0x	-0x
Capitalization / Revenue	2.76x	8.13x	3.09x	7.17x	1.06x	3.03x
EV / Revenue	2.02x	7.4x	2.22x	6.55x	1.03x	2.82x
EV / EBITDA	-15.6x	-124x	-38.9x	-20.1x	-9.16x	15.3x
EV / EBIT	-14.4x	-109x	-36.2x	-18.9x	-8.75x	16.2x
EV / FCF	20.4x	34.5x	12.4x	-63.8x	-3.81x	29.2x
FCF Yield	4.9%	2.9%	8.05%	-1.57%	-26.3%	3.42%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-0.009265	-0.007999	-0.003999	-0.0144	-0.069	0.023
Distribution rate	-	-	-	-	-	-
Net sales ¹	2.322	2.204	2.485	5.305	9.643	29.28
EBITDA ¹	-0.3009	-0.132	-0.1416	-1.726	-1.082	5.402
EBIT ¹	-0.3257	-0.1497	-0.1525	-1.836	-1.133	5.099
Net income ¹	-0.5931	-0.4957	-0.2365	-1.94	-13.33	4.901
Net Debt ¹	-1.7	-1.602	-2.168	-3.287	-0.3176	-6.134
Reference price ²	0.1000	0.2800	0.1200	0.2000	0.0500	0.4100
Nbr of stocks (in thousands)	64,015	64,015	64,015	190,165	204,665	216,483
Announcement Date	9/30/20	9/30/21	9/30/22	9/29/23	9/30/24	9/30/25

¹AUD in Million²AUD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
LONZA GROUP AG	34.55x	6.16x	18.31x	0.93%	51.14B
REVOLUTION MEDICINES, INC.	-22.47x	290.65x	-23.9x	-.--%	47.4B
IQVIA HOLDINGS INC.	33.79x	3.27x	14.13x	-.--%	43.19B
BEONE MEDICINES AG	48.79x	5.67x	30.99x	-.--%	42.35B
CELLTRION, INC.	29.05x	8.78x	22.18x	0.4%	33.23B
MEDPACE HOLDINGS, INC.	34.78x	5.7x	25.92x	-.--%	17.07B
EUROFINS SCIENTIFIC SE	24.34x	2.11x	9.14x	1.11%	14.76B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	79.29x	4.16x	16.13x	-.--%	14.15B
Average	32.77x	40.81x	14.11x	0.3%	32.91B
Weighted average by Cap.	27.60x	56.79x	12.42x	0.29%